Maui Imaging

Maui Imaging is a privately held American medical imaging company headquartered in San Jose, California. It was founded in 2006 with the stated goal of dramatically advancing medical imaging, bringing together experts in sonar, radar, electrical engineering, and medical imaging to rethink the cumbersome, expensive, and challenging approaches then used in clinical care. That research led the company to invent its own modality, Computed Echo Tomography (CET), which underpins its hardware and proprietary algorithms. According to the company, this intellectual property is secured by more than 160 U.S. and international patents, with over 30 more pending. The company's flagship product is the K3900 imaging system, which received FDA clearance in the fourth quarter of 2023. Maui Imaging markets the K3900 as a breakthrough that overcomes the limitations of traditional ultrasound, which struggles to see through and around obstacles such as bone, air, and metal. The company says the system can image through the skull and into the cranial vault, and it positions the technology for trauma and emergency-room use, critical care, neurology, and interventional radiology, as well as for real-time procedure guidance. Maui Imaging has pursued military and austere-environment applications. In the fourth quarter of 2023, when the K3900 received FDA clearance, the company entered into an expansive contract with the U.S. Department of Defense to assess its military applications "in the field." The company states that this award followed multiple test programs and reflects U.S. military confidence in the system's ability to evaluate traumatic injuries in austere environments, including remote or small settings such as a naval vessel where CT is unavailable. The DoD is described as looking at using the technology at scale to diagnose, triage, and monitor patients. Maui Imaging describes its mission as offering easy-to-use, patient-safe imaging systems that provide physicians with real-time imaging of all tissue types, to aid effective patient diagnostics and guidance, improve clinical outcomes, and save lives regardless of environment or infrastructure. The company partners with thought leaders in interventional radiology, trauma, and interventional pulmonology, and is advised by innovators in science and technology. Its leadership team includes founder and CEO Dave Specht, acting COO Rick Altinger, and chief medical officer Dr. John Cheronis, MD, PhD.

Maui Imaging was founded in 2006 with the goal of dramatically advancing medical imaging. Rather than iterating on existing clinical imaging approaches, the founders brought together experts in sonar, radar, electrical engineering, and medical imaging to address what the company describes as the cumbersome, expensive, and challenging nature of imaging technology in clinical care. After years of research, this interdisciplinary work led the company to invent Computed Echo Tomography (CET), a modality that forms the basis of its hardware and proprietary algorithms. The company states that its technology is protected by more than 160 U.S. and international patents, with over 30 additional patents pending. The company is headquartered in San Jose, California, and is privately held. Its leadership includes founder and CEO Dave Specht, acting COO Rick Altinger, and chief medical officer Dr. John Cheronis, MD, PhD, supported by a board of directors and a team responsible for quality, operations, hardware and software engineering, marketing and sales, and clinical operations. Maui Imaging's flagship product, the K3900 imaging system, received FDA clearance in the fourth quarter of 2023. The system is designed to overcome the limitations of traditional ultrasound, which cannot easily see through and around obstacles such as bone, air, and metal. The company highlights the K3900's ability to image through the skull and into the cranial vault, and it is pursuing clinical use cases in trauma and emergency medicine, critical care, neurology, and interventional radiology, as well as real-time procedure guidance. In the same quarter as its FDA clearance, Maui Imaging entered into an expansive contract with the U.S. Department of Defense to assess the K3900's military applications "in the field." According to the company, this award followed multiple test programs and reflects U.S. military confidence in the system's ability to evaluate traumatic injuries in austere environments. Test areas include the use of the system after traumatic injuries in remote or small places, such as on a naval vessel where CT is unavailable. The Department of Defense is described as looking at using the technology at scale to diagnose, triage, and monitor patients. Maui Imaging continues to engage in clinical studies intended to demonstrate the impact of its products across trauma diagnosis, critical care, neurology, and interventional radiology. The company partners with thought leaders in interventional radiology, trauma, and interventional pulmonology, and is advised by innovators in science and technology. Its stated mission is to offer easy-to-use, patient-safe imaging systems that provide physicians with real-time imaging of all tissue types, aiding effective patient diagnostics and guidance to improve clinical outcomes and save lives regardless of environment or infrastructure.

• 2023

  The K3900 imaging system receives FDA clearance.

• 2023

  Maui Imaging enters an expansive contract with the U.S. Department of Defense to assess military applications of the K3900.

• 2006

  Maui Imaging is founded, bringing together experts in sonar, radar, electrical engineering, and medical imaging.

• After years of research, the company invents Computed Echo Tomography (CET).

Developer of FDA-cleared, patient-safe imaging systems that see through bone, air, and metal, targeting trauma, critical care, neurology, and interventional radiology, including austere and military environments.

• K3900 imaging system

  FDA-cleared imaging system based on Computed Echo Tomography, capable of imaging through bone, air, and metal, including through the skull into the cranial vault.

• Computed Echo Tomography (CET)

  Proprietary imaging modality invented by Maui Imaging, protected by more than 160 U.S. and international patents with over 30 pending.

1. 1Home - Maui Imagingmauiimaging.com
2. 2About - Maui Imagingmauiimaging.com
3. 3Maui Imaging (United States) - Wikidatawikidata.org